Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 2Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6Diffuse Intrinsic Pontine Glioma 2Sarcoma 1Pancreatic Adenocarcinoma 1Neoplasms 1Muscle Invasive Bladder Urothelial Carcinoma 1Lymphoma, B-Cell 1Glioma 1Bone Neoplasms 1

Interventions

Interleukin 1 Receptor Antagonist Protein 1Gemcitabine 1Cisplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Pancreatic Adenocarcinoma × Gemcitabine × Clear all
NCT02550327 2021-06-22

Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

Baylor Research Institute

Phase EARLY_PHASE1 Completed
20 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡